{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:24:48Z","timestamp":1780590288407,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40801-021-00282-3","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:02:25Z","timestamp":1644512545000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database"],"prefix":"10.1007","volume":"9","author":[{"given":"Luis H.","family":"Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sainz-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-9004","authenticated-orcid":false,"given":"Ester","family":"Navarro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Salado-Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Sanz-Fadrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"J Thachil N Tang S Gando A Falanga M Cattaneo M Levi  2020 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 J Thromb Haemost 18 1023 1026 https:\/\/doi.org\/10.1111\/jth.14810","journal-title":"J Thromb Haemost"},{"key":"282_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/bjh.16727","volume":"189","author":"A Kollias","year":"2020","unstructured":"A Kollias KG Kyriakoulis E Dimakakos G Poulakou GS Stergiou K Syrigos 2020 Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action Br J Haematol 189 846 847 https:\/\/doi.org\/10.1111\/bjh.16727","journal-title":"Br J Haematol"},{"key":"282_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.maturitas.2020.05.022","volume":"138","author":"A Cagnacci","year":"2020","unstructured":"A Cagnacci G Bonaccorsi M Gambacciani V Leo De C Carlo Di G Bifulco  2020 Reflections and recommendations on the COVID-19 pandemic: should hormone therapy be discontinued? Maturitas 138 76 77 https:\/\/doi.org\/10.1016\/j.maturitas.2020.05.022","journal-title":"Maturitas"},{"key":"282_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1590\/1806-9282.66.3.366","volume":"66","author":"M de Paula Pereira","year":"2020","unstructured":"M Paula Pereira de E GomesLima C Vicente Serrano Junior 2020 Viral infections and atherothrombosis: another caution in the wake of COVID-19? Rev Assoc Med Bras 66 366 369 https:\/\/doi.org\/10.1590\/1806-9282.66.3.366","journal-title":"Rev Assoc Med Bras"},{"key":"282_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Z Varga AJ Flammer P Steiger M Haberecker R Andermatt AS Zinkernagel  2020 Endothelial cell infection and endotheliitis in COVID-19 Lancet 395 1417 1418 https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"282_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"H Han L Yang R Liu F Liu F Liu KL Wu  2020 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Clin Chem Lab Med 58 1116 1120 https:\/\/doi.org\/10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"key":"282_CR7","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"E Driggin","year":"2020","unstructured":"E Driggin MV Madhavan B Bikdeli T Chuich J Laracy G Biondi-Zoccai  2020 Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic J Am Coll Cardiol 75 2352 2371 https:\/\/doi.org\/10.1016\/j.jacc.2020.03.031","journal-title":"J Am Coll Cardiol"},{"key":"282_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"N Tang D Li X Wang Z Sun 2020 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost 18 844 847 https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"282_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/jth.14828","volume":"18","author":"J Wang","year":"2020","unstructured":"J Wang N Hajizadeh EE Moore RC McIntyre PK Moore LA Veress  2020 Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series J Thromb Haemost 18 1752 1755 https:\/\/doi.org\/10.1111\/jth.14828","journal-title":"J Thromb Haemost"},{"key":"282_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"FA Klok MJHA Kruip NJM Meer van der MS Arbous DAMPJ Gommers KM Kant  2020 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Thromb Res 191 145 147 https:\/\/doi.org\/10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"282_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/1806-9282.66.S2.22","volume":"66","author":"ALR Pires","year":"2020","unstructured":"ALR Pires JG Batista JM Aldrighi IFDS Massaia DM Delgado ES Ferreira-Filho  2020 Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic Rev Assoc Med Bras 66 Suppl 2 22 26 https:\/\/doi.org\/10.1590\/1806-9282.66.S2.22","journal-title":"Rev Assoc Med Bras"},{"key":"282_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"JM Jin P Bai W He F Wu XF Liu DM Han  2020 Gender differences in patients with COVID-19: focus on severity and mortality Front Public Health 8 152 https:\/\/doi.org\/10.3389\/fpubh.2020.00152","journal-title":"Front Public Health"},{"key":"282_CR13","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"W Guan Z Ni Y Hu W Liang C Ou J He  2020 Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708 1720 https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"282_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","volume":"192","author":"MY Abou-Ismail","year":"2020","unstructured":"MY Abou-Ismail D Citla Sridhar L Nayak 2020 Estrogen and thrombosis: a bench to bedside review Thromb Res 192 40 51 https:\/\/doi.org\/10.1016\/j.thromres.2020.05.008","journal-title":"Thromb Res"},{"key":"282_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","volume":"165","author":"C Oedingen","year":"2018","unstructured":"C Oedingen S Scholz O Razum 2018 Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose Thromb Res 165 68 78 https:\/\/doi.org\/10.1016\/j.thromres.2018.03.005","journal-title":"Thromb Res"},{"key":"282_CR16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","volume":"127","author":"I Martinelli","year":"2016","unstructured":"I Martinelli AWA Lensing S Middeldorp M Levi J Beyer-Westendorf BB Van  2016 Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use Blood 127 1417 1425 https:\/\/doi.org\/10.1182\/blood-2015-08-665927","journal-title":"Blood"},{"key":"282_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.maturitas.2020.04.019","volume":"137","author":"I Ram\u00edrez","year":"2020","unstructured":"I Ram\u00edrez E Viuda De la L Baquedano P Coronado P Llaneza N Mendoza  2020 Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: recommendations from the Spanish Menopause Society, Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia and Sociedad Espa\u00f1ola de Trombosis y Hemostasia Maturitas 137 57 62 https:\/\/doi.org\/10.1016\/j.maturitas.2020.04.019","journal-title":"Maturitas"},{"key":"282_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.medcle.2016.12.007","volume":"147","author":"C Aguirre","year":"2016","unstructured":"C Aguirre M Garc\u00eda 2016 Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system Med Cl\u00ednica (Engl Ed) 147 461 464 https:\/\/doi.org\/10.1016\/j.medcle.2016.12.007","journal-title":"Med Cl\u00ednica (Engl Ed)"},{"key":"282_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"EG Brown L Wood S Wood 1999 The Medical Dictionary for Regulatory Activities (MedDRA) Drug Saf 20 109 117 https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug Saf"},{"key":"282_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","volume":"44","author":"N Moore","year":"1997","unstructured":"N Moore C Kreft-Jais F Haramburu C Noblet M Andrejak M Ollagnier  1997 Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/non-case study in the French pharmacovigilance system database Br J Clin Pharmacol 44 513 518 https:\/\/doi.org\/10.1046\/j.1365-2125.1997.00615.x","journal-title":"Br J Clin Pharmacol"},{"key":"282_CR21","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/1097-0258(20001215)19:23<3199::AID-SIM621>3.0.CO;2-Q","volume":"19","author":"SJW Evans","year":"2000","unstructured":"SJW Evans 2000 Pharmacovigilance: a science or fielding emergencies? Stat Med 19 3199 3209 https:\/\/doi.org\/10.1002\/1097-0258(20001215)19:23<3199::AID-SIM621>3.0.CO;2-Q","journal-title":"Stat Med"},{"key":"282_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"KJ Rothman S Lanes ST Sacks 2004 The reporting odds ratio and its advantages over the proportional reporting ratio Pharmacoepidemiol Drug Saf 13 519 523 https:\/\/doi.org\/10.1002\/pds.1001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"282_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813.pub2","author":"M de Bastos","year":"2014","unstructured":"M Bastos de BH Stegeman FR Rosendaal A Hylckama Vlieg Van FM Helmerhorst T Stijnen  2014 Combined oral contraceptives: venous thrombosis Cochrane Database Syst Rev https:\/\/doi.org\/10.1002\/14651858.CD010813.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"282_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trsl.2020.06.011","volume":"225","author":"N Machin","year":"2020","unstructured":"N Machin MV Ragni 2020 Hormones and thrombosis: risk across the reproductive years and beyond Transl Res 225 9 19 https:\/\/doi.org\/10.1016\/j.trsl.2020.06.011","journal-title":"Transl Res"},{"key":"282_CR25","unstructured":"N\u00fa\u00f1ez DCDNM y DDC. Riesgo de tromboembolismo venoso en mujeres consumidoras de anticonceptivos hormonales combinados. 2016. http:\/\/www.scielo.sld.cu\/pdf\/san\/v20n12\/san142012.pdf. Accessed 10 Jan 2021."},{"key":"282_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","volume":"27","author":"R Sitruk-Ware","year":"2013","unstructured":"R Sitruk-Ware A Nath 2013 Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills Best Pract Res Clin Endocrinol Metab 27 13 24 https:\/\/doi.org\/10.1016\/j.beem.2012.09.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"282_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11154-011-9178-0","volume":"12","author":"TG Deloughery","year":"2011","unstructured":"TG Deloughery 2011 Estrogen and thrombosis: controversies and common sense Rev Endocr Metab Disord 12 77 84 https:\/\/doi.org\/10.1007\/s11154-011-9178-0","journal-title":"Rev Endocr Metab Disord"},{"key":"282_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijgo.12455","volume":"141","author":"MV Dragoman","year":"2018","unstructured":"MV Dragoman NK Tepper R Fu KM Curtis R Chou ME Gaffield 2018 A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception Int J Gynecol Obstet 141 287 294 https:\/\/doi.org\/10.1002\/ijgo.12455","journal-title":"Int J Gynecol Obstet"},{"key":"282_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1076029616683802","volume":"24","author":"A Gialeraki","year":"2018","unstructured":"A Gialeraki S Valsami T Pittaras G Panayiotakopoulos M Politou 2018 Oral contraceptives and HRT risk of thrombosis Clin Appl Thromb 24 217 225 https:\/\/doi.org\/10.1177\/1076029616683802","journal-title":"Clin Appl Thromb"},{"key":"282_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","volume":"126","author":"SN Tchaikovski","year":"2010","unstructured":"SN Tchaikovski J Rosing 2010 Mechanisms of estrogen-induced venous thromboembolism Thromb Res 126 5 11 https:\/\/doi.org\/10.1016\/j.thromres.2010.01.045","journal-title":"Thromb Res"},{"key":"282_CR31","doi-asserted-by":"publisher","unstructured":"Emans SJ, Laufer MR. Goldstein\u2019s pediatric and adolescent gynecology. In: Emans SJ, Laufer MR, editors. Lippincott Williams & Wilkins, 2011 ISBN: 978-1608316489, Hardback, 608 pages, \u00a3105.00. Obstet Gynaecol 2013;15:E3\u2013E3. https:\/\/doi.org\/10.1111\/j.1744-4667.2012.00150.x.","DOI":"10.1111\/j.1744-4667.2012.00150.x"},{"key":"282_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2890","volume":"339","author":"\u00d8 Lidegaard","year":"2009","unstructured":"\u00d8 Lidegaard E L\u00f8kkegaard AL Svendsen C Agger 2009 Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 b2890 https:\/\/doi.org\/10.1136\/bmj.b2890","journal-title":"Cite This BMJ"},{"key":"282_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1542\/peds.2010-2221","volume":"127","author":"CC Trenor","year":"2011","unstructured":"CC Trenor RJ Chung AD Michelson EJ Neufeld CM Gordon MR Laufer  2011 Hormonal contraception and thrombotic risk: a multidisciplinary approach Pediatrics 127 347 357 https:\/\/doi.org\/10.1542\/peds.2010-2221","journal-title":"Pediatrics"},{"key":"282_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4944","volume":"345","author":"S Mantha","year":"2012","unstructured":"S Mantha R Karp V Raghavan N Terrin KA Bauer JI Zwicker 2012 Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis Cite this as: BMJ 345 e4944 https:\/\/doi.org\/10.1136\/bmj.e4944","journal-title":"Cite this as: BMJ"},{"key":"282_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"L Hazell SAW Shakir 2006 Under-reporting of adverse drug reactions: a systematic review Drug Saf 29 385 396 https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-021-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-021-00282-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-021-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T06:23:14Z","timestamp":1652768594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-021-00282-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s40801-021-00282-3","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"29 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding or financial support was provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data supporting the findings in this study are available from the Spanish Pharmacovigilance System (SEFV-H). Restrictions apply to the availability of these data, which were provided by the SEFV-H. Data are available from the authors with the permission of SEFV-H.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"LM conceptualised and designed the study, RS acquired data, LM, EN, RS, MS and IS analysed, drafted, reviewed and approved the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}